Figure 6b,c shows that the numbers of IFN-γ-positive CD4+ or CD8+ T cells were significantly increased in the tumours treated with Taxol, PEG2k-Fmoc-NLG(L) or PTX/PEG2k-Fmoc-NLG(L). This evidence concerns the gene CD8A and neoplasm.